T. Rowe Price Associates

T. Rowe Price Associates’s ACELYRIN SLRN Stock Holding History

T. Rowe Price Associates’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$86K	Buy
2024 Q4	$84K	Buy
2024 Q3	$116K	Buy
2024 Q2	$102K	Buy
2024 Q1	$140K	Buy
2023 Q4	–	Sell
2023 Q3	$4.66M	Sell
2023 Q2	$18.6M	Buy